Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00717249 · ClinicalTrials.gov registry record · NA

Vistakon Investigational Contact Lenses Worn for Daily Wear

A NA study of Myopia, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
529
Enrollment target
20
Study locations

NCT00717249 is a NA study of Myopia that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 529 participants, above the 262-participant average among 90 other Myopia trials with a reported enrollment target (102% higher). The trial reports 20 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00717249, a NA study of Myopia, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
529 participants
Enrollment target
20
Study locations

Study Summary

This study compares the performance of an investigational contact lens to a currently marketed lens.

Conditions Studied

Interventions

  • DEVICE galyifilcon A control lens
  • DEVICE galyfilcon A with a silver additive

Study Locations (20)

Ohio

  • Drs. Quinn, Quinn and Associates - Athens
  • Dr. Michael H. Greenburg, Inc. - Chagrin Falls
  • Central Ohio Eyecare - Columbus
  • James W. Kershaw OD, Inc. - North Olmsted

Pennsylvania

  • West Hills Vision Center - Moon Township
  • Nittany Eye Associates - State College
  • Research Across America - Wyomissing

California

  • Cole, Cole, and Krohn - Fresno
  • Dr. James R. Dugue Family Optometrist - Mission Viejo

Colorado

  • Fukai and Associates - Louisville

Florida

  • Baymeadows Vision Center - Jacksonville

Illinois

  • Eyecare Associates - Bloomington

Kansas

  • Advantage Eyecare Associates, LLC - Neodesha

Missouri

  • InSight Eyecare - Warrensburg

Trial Details

FieldValue
Enrollment Target 529 participants
Start Date 2007-08
Est. Completion 2008-04
Phase NA

Sponsor

Johnson & Johnson Vision Care

142 total trials

What the Registry Record Tells You About NCT00717249

The ClinicalTrials.gov registry entry for NCT00717249 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 529 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 262-participant average among 90 other Myopia trials with a reported enrollment target (102% higher). The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which galyifilcon A control lens is the first listed.

NCT00717249 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Ohio, Pennsylvania, California.

Frequently Asked Questions

What is clinical trial NCT00717249 about?

NCT00717249 is a clinical study titled "Vistakon Investigational Contact Lenses Worn for Daily Wear". This study compares the performance of an investigational contact lens to a currently marketed lens.

What is the current status of trial NCT00717249?

This trial is currently completed. It is a NA study. The enrollment target is 529 participants. The study started on 2007-08. Estimated completion is 2008-04.

What conditions does trial NCT00717249 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT00717249?

The interventions under investigation include: galyifilcon A control lens (DEVICE), galyfilcon A with a silver additive (DEVICE).

Who is sponsoring clinical trial NCT00717249?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00717249 being conducted?

This trial has 20 study locations across California, Colorado, Florida, Illinois, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.